Friday, June 2, 2017

61 aka 6 years one month since diagnosis

Pulling away from the 5 year median survival.




at

1 comment:

Subscribe to: Post Comments (Atom)

Velcade and Ninlaro Webinars

Takeda has a couple of webinars coming up for two of the more common myeloma medicines. Register here.